A dendritic cell shot that targets survivin, tested in people with newly diagnosed glioblastoma after surgery
Original title: Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a mid stage trial, so the treatment is still being tested in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a cell injection given after brain surgery for a newly diagnosed glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary.
Who this trial is for. This trial is for people who have just been diagnosed with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary and have had surgery. It is testing a dendritic cell injection that targets a protein called survivin.
Where it stands. There are no results yet. The trial is set up to look at how well the injection works and how safe it is. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: For now this does not change the care your doctor can give you. If you have just been diagnosed with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary and had surgery, you could ask your care team if a trial like this is worth looking into for you.
What it doesn't mean: This does not mean the treatment works. A trial is a test, not a proven treatment. Being in a trial is not a guarantee that it will help you. It is not a promise of a cure, and it is not a treatment you can get from your own doctor today.
Source: ClinicalTrials.gov, July 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.